149 related articles for article (PubMed ID: 32645649)
1. Effect of sertraline in patients with newly diagnosed depression and type 2 diabetes mellitus or hypertension: An observational study from south India.
Padmapriya C; Pushkarapriya S; Shanmugapriya N; Sushmitha KP; Karthik S; Rajanandh MG
Diabetes Metab Syndr; 2020; 14(5):1065-1068. PubMed ID: 32645649
[TBL] [Abstract][Full Text] [Related]
2. Impact of sertraline on weight, waist circumference and glycemic control: A prospective clinical trial on depressive diabetic type 2 patients.
Rachdi C; Damak R; Fekih Romdhane F; Ouertani H; Cheour M
Prim Care Diabetes; 2019 Feb; 13(1):57-62. PubMed ID: 30287230
[TBL] [Abstract][Full Text] [Related]
3. Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial.
Lustman PJ; Clouse RE; Nix BD; Freedland KE; Rubin EH; McGill JB; Williams MM; Gelenberg AJ; Ciechanowski PS; Hirsch IB
Arch Gen Psychiatry; 2006 May; 63(5):521-9. PubMed ID: 16651509
[TBL] [Abstract][Full Text] [Related]
4. Sertraline in coexisting major depression and diabetes mellitus.
Goodnick PJ; Kumar A; Henry JH; Buki VM; Goldberg RB
Psychopharmacol Bull; 1997; 33(2):261-4. PubMed ID: 9230640
[TBL] [Abstract][Full Text] [Related]
5. Study protocol of the Diabetes and Depression Study (DAD): a multi-center randomized controlled trial to compare the efficacy of a diabetes-specific cognitive behavioral group therapy versus sertraline in patients with major depression and poorly controlled diabetes mellitus.
Petrak F; Herpertz S; Albus C; Hermanns N; Hiemke C; Hiller W; Kronfeld K; Kruse J; Kulzer B; Ruckes C; Müller MJ
BMC Psychiatry; 2013 Aug; 13():206. PubMed ID: 23915015
[TBL] [Abstract][Full Text] [Related]
6. Glycemic control improvement through treatment of depression using antidepressant drugs in patients with diabetes mellitus type 1.
Komorousova J; Beran J; Rusavy Z; Jankovec Z
Neuro Endocrinol Lett; 2010; 31(6):801-6. PubMed ID: 21196929
[TBL] [Abstract][Full Text] [Related]
7. Sertraline as monotherapy in the treatment of psychotic and nonpsychotic depression.
Simpson GM; El Sheshai A; Rady A; Kingsbury SJ; Fayek M
J Clin Psychiatry; 2003 Aug; 64(8):959-65. PubMed ID: 12927014
[TBL] [Abstract][Full Text] [Related]
8. Cognitive Behavioral Therapy Versus Sertraline in Patients With Depression and Poorly Controlled Diabetes: The Diabetes and Depression (DAD) Study: A Randomized Controlled Multicenter Trial.
Petrak F; Herpertz S; Albus C; Hermanns N; Hiemke C; Hiller W; Kronfeld K; Kruse J; Kulzer B; Ruckes C; Zahn D; Müller MJ
Diabetes Care; 2015 May; 38(5):767-75. PubMed ID: 25690005
[TBL] [Abstract][Full Text] [Related]
9. A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial.
Salaminios G; Duffy L; Ades A; Araya R; Button KS; Churchill R; Croudace T; Derrick C; Dixon P; Dowrick C; Gilbody S; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Lanham P; Malpass A; Peters TJ; Riozzie D; Robinson J; Sharp D; Thomas L; Welton NJ; Wiles N; Lewis G
Trials; 2017 Oct; 18(1):496. PubMed ID: 29065916
[TBL] [Abstract][Full Text] [Related]
10. Sertraline treatment of major depression in patients with acute MI or unstable angina.
Glassman AH; O'Connor CM; Califf RM; Swedberg K; Schwartz P; Bigger JT; Krishnan KR; van Zyl LT; Swenson JR; Finkel MS; Landau C; Shapiro PA; Pepine CJ; Mardekian J; Harrison WM; Barton D; Mclvor M;
JAMA; 2002 Aug; 288(6):701-9. PubMed ID: 12169073
[TBL] [Abstract][Full Text] [Related]
11. A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia.
Mulholland C; Lynch G; King DJ; Cooper SJ
J Psychopharmacol; 2003 Mar; 17(1):107-12. PubMed ID: 12680747
[TBL] [Abstract][Full Text] [Related]
12. Effect of oral vitamin D supplementation on glycemic control in patients with type 2 diabetes mellitus with coexisting hypovitaminosis D: A parellel group placebo controlled randomized controlled pilot study.
Upreti V; Maitri V; Dhull P; Handa A; Prakash MS; Behl A
Diabetes Metab Syndr; 2018 Jul; 12(4):509-512. PubMed ID: 29580871
[TBL] [Abstract][Full Text] [Related]
13. Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.
Ravindran AV; Guelfi JD; Lane RM; Cassano GB
J Clin Psychiatry; 2000 Nov; 61(11):821-7. PubMed ID: 11105734
[TBL] [Abstract][Full Text] [Related]
14. Placebo-controlled study of sertraline in depressed recently abstinent alcoholics.
Roy A
Biol Psychiatry; 1998 Oct; 44(7):633-7. PubMed ID: 9787889
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.
Mehtonen OP; Søgaard J; Roponen P; Behnke K
J Clin Psychiatry; 2000 Feb; 61(2):95-100. PubMed ID: 10732656
[TBL] [Abstract][Full Text] [Related]
16. Effect of Sudarshan Kriya Yoga on anxiety, depression, and quality of life in people with type 2 diabetes: A pilot study in Kuwait.
Shiju R; Thomas D; Al Arouj M; Sharma P; Tuomilehto J; Bennakhi A
Diabetes Metab Syndr; 2019; 13(3):1995-1999. PubMed ID: 31235126
[TBL] [Abstract][Full Text] [Related]
17. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
Luque Otero M; Martell Claros N;
Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
[TBL] [Abstract][Full Text] [Related]
18. Impact of type 2 diabetes mellitus on left ventricular diastolic function in patients with essential hypertension: evaluation by volume-time curve of cardiac magnetic resonance.
Yan WF; Gao Y; Zhang Y; Guo YK; Wang J; Jiang L; Li Y; Yang ZG
Cardiovasc Diabetol; 2021 Mar; 20(1):73. PubMed ID: 33766020
[TBL] [Abstract][Full Text] [Related]
19. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.
Fava M; Rosenbaum JF; Hoog SL; Tepner RG; Kopp JB; Nilsson ME
J Affect Disord; 2000 Aug; 59(2):119-26. PubMed ID: 10837880
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Sertraline in Patients With Major Depressive Disorder Naive to Selective Serotonin Reuptake Inhibitors: A 10-Week Randomized, Multicenter, Placebo-Controlled, Double-Blind, Academic Clinical Trial.
Valle-Cabrera R; Mendoza-Rodríguez Y; Robaina-García M; Ballesteros J; Cordero-Jiménez JR; Espinosa-Rodríguez NB; Sotolongo-Garcia Y; Lauria-Horner B;
J Clin Psychopharmacol; 2018 Oct; 38(5):454-459. PubMed ID: 30106883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
